|
⚲
|
| Keyboard |
| Arch Venture Partners X Overage LP | |
|---|---|
| Firm | Arch Venture Management LLC |
| Address | c/o Arch Venture Corporation 8755 W Higgins Road, Suite 1025 Chicago, IL 60631 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Arch Venture Management LLC | |||||
| Arch Venture Fund X Overage LP | 021-324501 | Director | 635.8 M of 675.0 M |
530.4 M | |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Neumora Therapeutics Inc NMRA
Common Stock
|
2025-10-27 | Buy | 1,915,700 | $2.61 | 4,999,977 |
|
Prime Medicine Inc PRME
Common Stock
|
2025-08-01 | Buy | 3,030,300 | $3.30 | 9,999,990 |
|
Boundless Bio Inc BOLD
Common Stock
|
2024-04-02 | Conversion | 1,048,433 | ||
|
Boundless Bio Inc BOLD
Series A Convertible Preferred Stock · derivative
|
2024-04-02 | Conversion | 424,908 | ||
|
Boundless Bio Inc BOLD
Series C Convertible Preferred Stock · derivative
|
2024-04-02 | Conversion | 366,301 | ||
|
Boundless Bio Inc BOLD
Common Stock
|
2024-04-02 | Conversion | 589,743 | ||
|
Boundless Bio Inc BOLD
Common Stock
|
2024-04-02 | Buy | 133,333 | $16.00 | 2,133,328 |
|
Boundless Bio Inc BOLD
Common Stock
|
2024-04-02 | Conversion | 787,545 | ||
|
Boundless Bio Inc BOLD
Common Stock
|
2024-04-02 | Buy | 66,667 | $16.00 | 1,066,672 |
|
Boundless Bio Inc BOLD
Series C Convertible Preferred Stock · derivative
|
2024-04-02 | Conversion | 201,465 | ||
|
Boundless Bio Inc BOLD
Series C Convertible Preferred Stock · derivative
|
2024-04-02 | Conversion | 164,835 | ||
|
Boundless Bio Inc BOLD
Series B Convertible Preferred Stock · derivative
|
2024-04-02 | Conversion | 227,920 | ||
|
Boundless Bio Inc BOLD
Series A Convertible Preferred Stock · derivative
|
2024-04-02 | Conversion | 454,212 | ||
|
Boundless Bio Inc BOLD
Series A Convertible Preferred Stock · derivative
|
2024-04-02 | Conversion | 586,080 | ||
|
Prime Medicine Inc PRME
Common Stock
|
2024-02-15 | Buy | 3,200,000 | $6.25 | 20,000,000 |
|
Sana Biotechnology Inc SANA
Common Stock
|
2024-02-08 | Buy | 363,637 | $5.50 | 2,000,004 |
|
Sana Biotechnology Inc SANA
Common Stock
|
2024-02-08 | Buy | 727,272 | $5.50 | 3,999,996 |
|
Sana Biotechnology Inc SANA
Common Stock
|
2024-02-08 | Buy | 727,272 | $5.50 | 3,999,996 |
|
Neumora Therapeutics Inc NMRA
Common Stock
|
2023-12-08 | Other | 1,176,593 | ||
|
Neumora Therapeutics Inc NMRA
Common Stock
|
2023-12-08 | Other | 703,061 | ||
| showing 20 of 70 most recent transactions | |||||